BMS-181339

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMS-181339, covering 2021-05-25 to 2022-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer [Phase 2]